David M Gau

7PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Neurology and neuromuscular diseasesInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 25, 2026
Survivin drives renal cell carcinoma tumorigenesis via proliferative and metabolic adaptation.

|Jun 04, 2026
Microplastics inhibit macrophage bioenergetics impairing homeostatic function and immune responsiveness.

|May 25, 2026
Profilin-1 Promotes Chromophobe Renal Cell Carcinoma Malignancy.

|Jan 08, 2026
Mitochondria and the Actin Cytoskeleton in Neurodegeneration.

Shivani Tuli, Preet Patel, Aneri Shethji

|Sep 15, 2025
Survivin as a Multifaceted Oncogenic Driver and Therapeutic Target in Renal Cell Carcinoma.

Shivani Tuli, Gabrielle Inserra, Yamato Murakami

|Oct 02, 2023
Vascular endothelial cell-specific disruption of the profilin1 gene leads to severe multiorgan pathology and inflammation causing mortality.

Abigail Allen-Gondringer, David Gau, Christopher Varghese

Pageof 2

Frequent Collaborators

3 joint publications

Shivani Tuli

2 joint publications

Yongho Bae

1 joint publications

Sarvesh Senguttavan

1 joint publications

Abigail Allen-Gondringer